Invesco India Pharma and Healthcare Fund

    +6.5%Since Sept 2026

    NAV ₹10.65 · 19 Nov

    NAV by date
    DateNAV
    7 Sept 2026₹10.00
    11 Sept 2026₹9.99
    16 Sept 2026₹9.88
    18 Sept 2026₹10.05
    22 Sept 2026₹10.04
    24 Sept 2026₹10.03
    28 Sept 2026₹9.85
    30 Sept 2026₹9.59
    5 Oct 2026₹9.41
    7 Oct 2026₹9.46
    9 Oct 2026₹9.38
    13 Oct 2026₹9.25
    16 Oct 2026₹9.07
    21 Oct 2026₹8.97
    23 Oct 2026₹8.95
    27 Oct 2026₹9.45
    29 Oct 2026₹9.56
    2 Nov 2026₹9.71
    4 Nov 2026₹10.03
    6 Nov 2026₹10.25
    11 Nov 2026₹10.53
    13 Nov 2026₹10.58
    17 Nov 2026₹10.60
    19 Nov 2026₹10.65

    An open-ended sectoral fund from Invesco Mutual Fund, Direct plan since September 2026. Figures for the Direct plan, Growth option.

    Fund size
    ₹476 Cr
    Category median ₹569 Cr
    Expense ratio
    3.30%
    Category 1.01%
    Deepest fall, whole history
    −11.4%
    Now 0.0%
    Top 10 holdings
    78.2%
    17 holdings

    Returns against the category

    PeriodThis fundFundCategory medianCategory
    1 month1M18.3%9.0%
    3 months3M–2.2%
    6 months6M–9.9%
    1 year1Y–4.8%
    3 years (a year)3Y–14.2%
    5 years (a year)5Y–14.0%
    10 years (a year)10Y–16.5%
    Since launch (a year)Launch6.5%12.4%
    Returns up to 19 Nov 2026. Up to a year: absolute; longer: a year (CAGR).

    Ups and downs

    0.0%below its previous high

    Now · deepest ever −11.4% · chart from September 2026

    Fall from the previous high, by date
    DateBelow peak
    7 Sept 20260.0%
    11 Sept 2026−0.3%
    16 Sept 2026−1.4%
    18 Sept 20260.0%
    22 Sept 2026−0.4%
    24 Sept 2026−0.7%
    28 Sept 2026−2.5%
    30 Sept 2026−5.0%
    5 Oct 2026−6.8%
    7 Oct 2026−6.3%
    9 Oct 2026−7.1%
    13 Oct 2026−8.4%
    16 Oct 2026−10.2%
    21 Oct 2026−11.2%
    23 Oct 2026−11.4%
    27 Oct 2026−6.4%
    29 Oct 2026−5.3%
    2 Nov 2026−3.9%
    4 Nov 2026−0.7%
    6 Nov 20260.0%
    11 Nov 20260.0%
    13 Nov 20260.0%
    17 Nov 20260.0%
    19 Nov 20260.0%
    Volatility (3Y)
    –standard deviation, a year
    Deepest fall
    −11.4%from a peak, whole history

    What it holds

    Portfolio as disclosed for October 2026: 17 holdings, the ten largest 78.2% of the fund.

    Asset mix
    • Equity97.1%
    • Cash and equivalents2.9%
    By company size
    • Large cap30.6%
    • Mid cap18.7%
    • Small cap32.5%
    Sectors
    • Health Care97.1%
    • Others3.2%

    Largest holdings

    1. Apollo Hospitals Enterprise LimitedHealthcare Services9.08%
    2. Divi's Laboratories LimitedPharmaceuticals & Biotechnology8.74%
    3. Max Healthcare Institute LimitedHealthcare Services8.59%
    4. Sai Life Sciences LimitedPharmaceuticals & Biotechnology8.49%
    5. Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology8.31%
    6. Manipal Health Enterprises LtdHealthcare Services7.97%
    7. Dr Agarwals Health Care LimitedHealthcare Services7.93%
    8. Sahajanand Medical Technologies LimitedHealthcare Equipment & Supplies7.31%
    9. Global Health LimitedHealthcare Services5.96%
    10. Corona Remedies LimitedPharmaceuticals & Biotechnology5.76%

    Fund size over time

    ₹476 CrOctober 2026

    From ₹436 Cr in September 2026; all plans together

    Fund size by month end
    Month endFund size
    30 Sept 2026₹436 Cr
    31 Oct 2026₹476 Cr

    Key facts

    Plan and option
    Direct plan, Growth option
    Launched
    7 Sept 2026
    Benchmark
    BSE Health Care - TRI
    Fund manager
    Aditya Khemani
    Exit load
    Exit Load^: For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP), Systematic Transfer Plan (STP) and IDCW Transfer Plan, exit load will be as follows: if units are redeemed/switched out on or before 3 months from the date of allotment: 0.50% if units are redeemed/switched-out after 3 months: Nil Switch between the Plans under the Scheme: Nil ^Exit Load charged, if any, will be credited back to the scheme, net of Goods and Services Tax
    Minimum investment
    SIP ₹100 a month · one-time ₹1,000
    ISIN
    INF205KA1BX5

    Other Sectoral funds

    The largest other funds in the category by fund size, not a ranking. All Sectoral funds · Compare side by side

    Questions about Invesco India Pharma and Healthcare Fund

    What is the expense ratio of Invesco India Pharma and Healthcare Fund?

    The Direct plan's expense ratio is 3.30% a year as of 31 Oct 2026. It is taken out of the fund's assets every day, so the NAV and the returns shown are already after it.

    How large is Invesco India Pharma and Healthcare Fund?

    Invesco India Pharma and Healthcare Fund manages ₹476 Cr as of 31 Oct 2026.

    How much does Invesco India Pharma and Healthcare Fund go up and down?

    Its largest fall from a peak over its whole history was 11.4%.

    What is the benchmark of Invesco India Pharma and Healthcare Fund?

    The fund measures itself against the BSE Health Care - TRI.

    Who manages Invesco India Pharma and Healthcare Fund?

    Aditya Khemani manages the fund.

    Is there an exit load on Invesco India Pharma and Healthcare Fund?

    Exit load: Exit Load^: For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP), Systematic Transfer Plan (STP) and IDCW Transfer Plan, exit load will be as follows: if units are redeemed/switched out on or before 3 months from the date of allotment: 0.50% if units are redeemed/switched-out after 3 months: Nil Switch between the Plans under the Scheme: Nil ^Exit Load charged, if any, will be credited back to the scheme, net of Goods and Services Tax.

    What is the minimum investment in Invesco India Pharma and Healthcare Fund?

    A SIP can start from ₹100 a month. A one-time investment can start from ₹1,000.

    About the fund house, Invesco Mutual Fund

    Invesco Mutual Fund runs 47 funds on this site, managing ₹1,66,440 Cr together.

    See every Invesco Mutual Fund fund